Breast Cancer News and Research

Latest Breast Cancer News and Research

Novel DNA-altering method could lead to more treatment options for diseases

Researchers in Singapore have developed a new protein that can alter DNA in living cells with much higher precision than current methods.

13 Sep 2016

Using the immune system to fight cancer: an interview with Dr Charles Akle

We all produce as many as 100,000 different types of cancer cells every day, which are recognized and eliminated by our extraordinarily efficient immune system. However, if something goes wrong with the immune system, and it no longer gets rid of these cells, then that’s when cancerous cells grow and become a problem.

12 Sep 2016

Penn researchers develop open-source software to infer evolutionary track of tumor metastasis

Individual cells within a tumor are not all the same. This may sound like a modern medical truism, but it wasn't very long ago that oncologists assumed that taking a single biopsy from a patient's tumor would be an accurate reflection of the physiological and genetic make-up of the entire mass.

9 Sep 2016

Oncovision’s preclinical PET imaging business acquired in agreement with Bruker

PET and SPECT are key molecular imaging technologies for Bruker’s Preclinical Imaging division, allowing Bruker to offer the highest-performance SiPM-PET/SPECT/CT and integrated SiPM-PET/MR imaging systems.

From Bruker BioSpin - NMR, EPR and Imaging 9 Sep 2016

Interactions between tumor cells and platelets could lead to cancer metastasis

Metastasis of cancer cells to sites distant from the primary tumor is the leading cause of cancer-related death, and there is growing evidence that platelets aid the dissemination of cancer cells.

9 Sep 2016

Researchers reveal how traditional Chinese medicine helps treat various cancers

Researchers at the University of Adelaide have shown how a complex mix of plant compounds derived from ancient clinical practice in China - a Traditional Chinese Medicine - works to kill cancer cells.

8 Sep 2016

Researchers unlock genetic code that disrupts response to breast cancer therapy

Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen.

7 Sep 2016

RIT and Rochester Regional Health team up to advance thermal imaging for breast cancer detection

Researchers at Rochester Institute of Technology and physicians at Rochester Regional Health are advancing thermal imaging techniques as a potentially safer and less invasive diagnostic tool for the detection of early-stage breast cancer.

7 Sep 2016

New computer program can predict underlying genomics of ER+ breast cancer

The number of tubules in tumors may predict which women with estrogen receptor positive (ER+) breast cancer will benefit from hormone therapy alone and which require chemotherapy, researchers at Case Western Reserve University have found.

7 Sep 2016

New drug holds potential for treating advanced mastocytosis

Most people have never heard of mastocytosis. It's a rare, sometimes deadly, immune disorder. Now new research may help those with advanced mastocytosis and possibly many more people, too.

6 Sep 2016

NICE MIB offers SD-IORT using Xoft Axxent electronic brachytherapy system for early stage breast cancer patients

NICE (National Institute for Health and Care Excellence) has announced a new Medtech Innovation Briefing (MIB) stating that NHS doctors and commissioners may consider Single Dose Intraoperative Radiotherapy (SD-IORT) using the Xoft Axxent electronic brachytherapy system with ORL managed service as a treatment option for early stage breast cancer patients.

6 Sep 2016

Blood cancer treatment linked to distinct increase in molecular age of immune cells

Certain cancer treatments are known to take a toll on patients, causing side effects like fatigue, nausea and hair loss. Now, scientists are investigating whether some treatments can cause another long-term side effect: premature aging of important disease-fighting cells.

1 Sep 2016

New research explores challenges faced by African American breast cancer survivors

Although there is some overlap, past research has shown that the challenges faced by African American breast cancer survivors differ somewhat from Caucasian women.

1 Sep 2016

Scientists combine immunotherapy with chemotherapy to eliminate cancer recurrence

Scientists from the United States have made an important step toward eliminating cancer recurrence by combining immunotherapy with chemotherapy.

1 Sep 2016

Study collects data on 30-day mortality for breast, lung cancer patients after SACT to improve patient care

For the first time, national data on 30-day mortality for patients with breast and lung cancer treated with chemotherapy have been collected and analysed in order to help clinical teams review and improve patient care, and identify groups of patients who may have additional needs.

31 Aug 2016

Breastfeeding for longer than 6 months can lower breast cancer mortality risk

A new study of women 20 years after undergoing surgery for primary breast cancer shows that breastfeeding for longer than 6 months is associated with a better survival rate.

31 Aug 2016

Experimental drug may become key tool to target triple-negative breast cancer with immunotherapy

Previous studies at the University of Colorado Cancer Center show that the experimental drug AMPI-109 potently kills triple-negative breast cancer cells.

30 Aug 2016

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

30 Aug 2016

NEJM publishes MINDACT trial results

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces the peer-reviewed publication of the primary outcome results of the Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid ChemoTherapy (MINDACT) clinical trial in the prestigious New England Journal of Medicine (NEJM). (i, iii, iv) The publication demonstrates that 46% of breast cancer patients considered for chemotherapy, whose tumors are classified MammaPrint Low Risk, have excellent survival without chemotherapy, and can thus be candidates to avoid this toxic therapy.

29 Aug 2016

Sanford-NDSU Collaborative Seed Grant Program provides funding for three health research projects

Three research projects have received $250,000 in seed funding from the Sanford Health NDSU Collaborative Seed Grant program. NDSU researchers will have opportunities to collaborate with investigators from Sanford Research.

28 Aug 2016

Breast Cancer News and Research

Latest Breast Cancer News and Research

Novel DNA-altering method could lead to more treatment options for diseases

Using the immune system to fight cancer: an interview with Dr Charles Akle

Penn researchers develop open-source software to infer evolutionary track of tumor metastasis

Oncovision’s preclinical PET imaging business acquired in agreement with Bruker

Interactions between tumor cells and platelets could lead to cancer metastasis

Researchers reveal how traditional Chinese medicine helps treat various cancers

Researchers unlock genetic code that disrupts response to breast cancer therapy

RIT and Rochester Regional Health team up to advance thermal imaging for breast cancer detection

New computer program can predict underlying genomics of ER+ breast cancer

New drug holds potential for treating advanced mastocytosis

NICE MIB offers SD-IORT using Xoft Axxent electronic brachytherapy system for early stage breast cancer patients

Blood cancer treatment linked to distinct increase in molecular age of immune cells

New research explores challenges faced by African American breast cancer survivors

Scientists combine immunotherapy with chemotherapy to eliminate cancer recurrence

Study collects data on 30-day mortality for breast, lung cancer patients after SACT to improve patient care

Breastfeeding for longer than 6 months can lower breast cancer mortality risk

Experimental drug may become key tool to target triple-negative breast cancer with immunotherapy

Nebivolol treatment may protect against antracycline-induced cardiotoxicity in breast cancer patients

NEJM publishes MINDACT trial results

Sanford-NDSU Collaborative Seed Grant Program provides funding for three health research projects

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in